Society for Inherited Metabolic Disorders Annual Meeting

摘要 遗传性代谢障碍协会（SIMD）请求支持为学员提供奖学金， 出席2023年至2027年的年度会议。2022年会议将于4月10日至13日在佛罗里达州奥兰多举行， 2022. 2022年的会议将得到先前赠款的无成本延长的支持。2023年会议将在 2023年3月18日至21日在湖城与美国医学遗传学学院联合举行 （ACMG）会议结束后。2024年的会议是TBD。2025年会议将与 在日本京都举行的先天性代谢缺陷国际大会上。2026年的会议是TBD。2027年 会议待定。 先天性代谢缺陷（IEM）是导致智力残疾、脑瘫、神经肌肉性瘫痪、脑性 疾病、心脏病、肝和肾功能障碍、关节炎、糖尿病、生长衰竭和失明。作为 这些疾病的广泛临床和分子谱正在被阐明，部分原因是 串联质谱和新生儿筛查计划的快速扩展，受影响的人数 现在已知的个体比最初认识的要大得多。此外，治疗方法可用于 一些条件下，但很少有临床试验已经进行，以评估其疗效。因此，仍有许多工作要做， 为了更好地了解这些严重的疾病，并为它们开发有效的治疗方法，我们必须做些什么。为美国 为了确保在这一重要研究领域保持卓越地位，必须吸引年轻的研究人员进入这一领域。 实现这一目标的一个有效机制是为他们提供参与SIMD的机会 会议，在那里他们可以探索该领域，并与其他已建立的研究人员建立科学联系。所述SIMD 每年举行一次会议，参加会议的人，特别是年轻的调查人员，每年都在稳步增加。 年NIH旅行奖励的可用性是这一增长的主要原因。寻求资助的受训人员 被要求提交一份摘要，描述将在会议上提出的原始研究。我们预计 受训人员/年轻调查员提交40份摘要，供在每次会议上介绍， 国际会议的编号（2025年）。将对旅行奖励申请进行竞争性审查4 在每次会议之前的几个月，目标是为国家提供10个每年1,000美元的奖项。 国际会议最多可获得5个2,000美元的奖项。将从私人部门筹集更多资金。 源将积极招聘妇女和少数民族申请人。

ABSTRACT The Society for Inherited Metabolic Disorders (SIMD) requests support to provide scholarships for trainees to attend its annual meetings in years 2023 to 2027. The 2022 meeting will be held in Orlando, FL April 10-13, 2022. The 2022 meeting will be supported by no-cost extension of the previous grant. The 2023 meeting will be held in Salt Lake City, UT March 18-21, 2023 in conjunction with the American College of Medical Genetics (ACMG) following their meeting. The 2024 meeting is TBD. The 2025 meeting will be held in conjunction with the International Congress on Inborn Errors of Metabolism in Kyoto, Japan. The 2026 meeting is TBD. The 2027 meeting is TBD. Inborn errors of metabolism (IEM) are an important cause of intellectual disability, cerebral palsy, neuromuscular disease, cardiac disorders, hepatic and renal dysfunction, arthritis, diabetes, growth failure and blindness. As the wide clinical and molecular spectrum of these disorders is being elucidated, in part fueled by the development of tandem mass spectroscopy and the rapid expansion of newborn screening programs, the number of affected individuals is now known to be much larger than originally recognized. In addition, therapies are available for some conditions, but few clinical trials have been performed to evaluate their efficacy. Thus, much remains to be done to better understand these severe disorders and develop effective treatments for them. For the U.S. to remain pre-eminent in this important area of research, it is essential to attract young investigators into the field. One effective mechanism to achieve this goal is to provide them with the opportunity to participate in the SIMD meeting, where they can explore the field and develop scientific ties to other established investigators. The SIMD meeting is held annually and participation, especially by young investigators, has been steadily increasing each year. The availability of NIH travel awards has been a major reason for this increase. Trainees seeking funding are required to submit an abstract describing original research to be presented at the meeting. We anticipate submission of 40 abstracts for presentation at each meeting from trainees/young investigators with twice that number for the international meeting (2025). Applications for travel awards will be competitively reviewed 4 months prior to each meeting, with the goal of making up 10 annual awards of $1,000 each for the national meeting and up to 5 awards of $2,000 for the International meeting. Additional funds will be solicited from private sources. Women and minority applicants will be actively recruited.